• Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha 410011, China;
GaoLing, Email: gaoling6287@163.com
Export PDF Favorites Scan Get Citation

Laser photocoagulation, intravitreal injection of antibody against vascular endothelial growth factor (VEGF) or corticosteroids and pars plana vitrectomy are current popular therapeutic approaches for diabetic retinopathy (DR). However, some DR patients still progress to irreversible blindness even after the above treatments which do not aim at the pathological mechanisms and influence factors for DR. Thus, with the further elucidation on the molecular pathological mechanisms and overall understanding of the factors affecting DR development, more and more potential therapeutic interventions such as neuron protection, vascular reconstruction and protection, gene therapy, non-VEGF dependent anti-neovascularization agents have been explored. Individual precise therapy based on the potential therapeutic targets would provide the promising future for DR patients.

Citation: LiuYuhua, GaoLing. The status, problem and progress of diabetic retinopathy treatment. Chinese Journal of Ocular Fundus Diseases, 2016, 32(2): 206-210. doi: 10.3760/cma.j.issn.1005-1015.2016.02.024 Copy

  • Previous Article

    先天性黄斑缺损继发视网膜脱离二例
  • Next Article

    The status and progress of relationship between dyslipidemia and diabetic retinopathy